Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dow Corning Reorganization Plan Appeals Could Delay Further Action

This article was originally published in The Gray Sheet

Executive Summary

Appeals based on lingering concerns over the fairness of Dow Corning's Chapter 11 bankruptcy reorganization plan are among potential roadblocks that could delay further action following approval by U.S. Bankruptcy Court Judge Arthur Spector on Nov. 30, plaintiffs' attorneys say.

You may also be interested in...

Breast Implant Litigation

Proponents of the Dow Corning Joint Plan of Reorganization will present evidence at a June 28 confirmation hearing in the U.S. Bankruptcy Court in Bay City, Michigan in an effort to obtain approval on the plan from the court. On June 1, the Tort Claimants Committee and Dow Corning announced acceptance of the settlement proposal. With more than 300,000 claimant votes submitted on various claim categories, 94% voted in favor of the plan. Court confirmation would allow claimants to select the settlement method for their claim and would resolve the company's Chapter 11 filing

Dow Corning Implant Claimants Could Receive Payments Starting June 1999

Dow Corning could begin paying silicone-filled breast implant claimants as early as June 1999 pending approval by U.S. Bankruptcy Court Judge Arthur Spector of a $3.2 bil. settlement.

Hanmi And LG Chem Highlight Vaccine Prowess, Novel R&D At JPM

Hanmi showcases at JPM its contract production capabilities for COVID-19 vaccines as South Korea prepares to bring in candidates from several global developers, while LG Chem highlights progress across multiple pipeline projects.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts